tradingkey.logo
tradingkey.logo
Pesquisar

Bionano Genomics Inc

BNGO
Adicionar à lista de desejos
1.150USD
-0.020-1.71%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
12.35MValor de mercado
PerdaP/L TTM

Mais detalhes de Bionano Genomics Inc Empresa

Bionano Genomics, Inc. is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).

Informações de Bionano Genomics Inc

Código da empresaBNGO
Nome da EmpresaBionano Genomics Inc
Data de listagemAug 01, 2018
CEOHolmlin (R. Erik)
Número de funcionários98
Tipo de títulosOrdinary Share
Fim do ano fiscalAug 01
Endereço9540 Towne Centre Drive
CidadeSAN DIEGO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal92121
Telefone18588887600
Sitehttps://bionano.com/
Código da empresaBNGO
Data de listagemAug 01, 2018
CEOHolmlin (R. Erik)

Executivos da empresa Bionano Genomics Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
619.00
-4.36%
Mr. Mark Adamchak
Mr. Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
254.00
-2.76%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
107.00
+84.11%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--
Dr. Albert A. Luderer, Ph.D.
Dr. Albert A. Luderer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Kristiina Vuori, M.D., Ph.D.
Dr. Kristiina Vuori, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Yvonne Linney, Ph.D.
Dr. Yvonne Linney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Alka Chaubey, Ph.D.
Dr. Alka Chaubey, Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
619.00
-4.36%
Mr. Mark Adamchak
Mr. Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
254.00
-2.76%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
107.00
+84.11%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--

Perguntas frequentes

Quem são os cinco principais acionistas de Bionano Genomics Inc?

Os cinco principais acionistas de Bionano Genomics Inc são: Mr. Mark Oldakowski

Quantas instituições possuem ações da Bionano Genomics Inc (BNGO)?

Em 2026Q1, 109 instituições possuíam ações da Bionano Genomics Inc, com valor de mercado aproximado de 1.17M, representando 10.52% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 32263.00.

Qual é a maior fonte de receita da Bionano Genomics Inc?

Em 2026Q1, o segmento de negócios Consumables gerou a maior receita para Bionano Genomics Inc, totalizando 13.97M e representando 49.00% da receita total.